Omeros Announces FDA Grants Fast Track Designation to Complement Inhibitor OMS721 for aHUS
July 23, 2015 at 07:09 AM EDT
Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to ...
